ArticleAntibiotics (Basel, Switzerland)2026
Bacteriophage-Based Control of Methicillin-Resistant
Article in Antibiotics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Biofilm-Forming Methicillin-Resistant Staphylococcus aureus: A Comprehensive Phenotypic and Genotypic Review.Cureus · 2026Review
- AFrontiers in microbiology · 2026Article
- Comprehensive characterization ofCurrent research in food science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
BACKGROUND/
objectivesMethicillin-resistant
methodsStaphylococcus-infecting bacteriophages were isolated from environmental sources and examined against reference
resultsTime-resolved infection assays revealed a multiplicity-of-infection-dependent reduction in viable MRSA, with a pronounced decrease observed approximately 40 min post-infection. At this time point, phage-treated cultures showed a reduction of 1.2-1.8 log
conclusionsTherefore, these findings suggest that bacteriophage-based approaches may be feasible for MRSA surface decontamination, while clearly emphasizing the need for context-specific validation before practical implementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.